The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Xanthine oxidoreductase in cancer: more than a differentiation marker
Open accessAbstract
Human xanthine oxidoreductase (XOR) catalyzes the last two steps of purine catabolism and is present in two interconvertible forms, which may utilize O 2 or NAD+ as electron acceptors. In addition to uric acid, XOR products may comprise reactive oxygen and nitrogen species that have many biologic effects, including inflammation, endothelial dysfunction, and cytotoxicity, as well as mutagenesis and induction of proliferation. XOR is strictly modulated at the transcriptional and post‐translational levels, and its expression and activity are highly variable in cancer. Xanthine oxidoreductase (XOR) expression has been negatively associated with a high malignity grade and a worse prognosis in neoplasms of the breast, liver, gastrointestinal tract, and kidney, which normally express a high level of XOR protein. However, the level of XOR expression may be associated with a worse outcome in cancer of low XOR‐expressing cells, in relation to the inflammatory response elicited through the tissue damage induced by tumor growth. Xanthine oxidoreductase (XOR) has been implicated in the process of oncogenesis either directly because it is able to catalyze the metabolic activation of carcinogenic substances or indirectly through the action of XOR‐derived reactive oxygen and nitrogen species. The role of uric acid is characterized by both oxidant and antioxidant action; thus, it is still debatable whether control of uricemia may be helpful to improve the outcomes of tumor illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelli, M. G., Bolognesi, A., & Polito, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.022 · Cited by 256 · cited 2×
“Such conversion may occur in different pathologic circumstances, including tissue damage by physical agents, poisoning with endogenous or toxic substances, and various hypoxic/ischemic conditions (reviewed in [4]).”
BackgroundSelf-citationXanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
Battelli, M. G., Polito, L., & Bolognesi, A. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.006 · Cited by 179 · cited 1×
“Both ROS and RNS may have many biologic effects, including endothelial dysfunction, inflammation, induction of proliferation, mutagenesis, and cytotoxicity (reviewed in [4, 5]) (Fig.”
BackgroundSelf-citation
Cited by
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
Xanthine oxidoreductase: One enzyme for multiple physiological tasks
Bortolotti, M., Polito, L., Battelli, M. G., & Bolognesi, A. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101882 · Cited by 395
Self-citationXanthine Oxidoreductase‐Derived Reactive Species: Physiological and Pathological Effects
Battelli, M. G., Polito, L., Bortolotti, M., & Bolognesi, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3527579 · Cited by 281
Self-citationPro-Aging Effects of Xanthine Oxidoreductase Products
Battelli, M. G., Bortolotti, M., Bolognesi, A., & Polito, L. (2020) · Antioxidants · doi:10.3390/antiox9090839 · Cited by 38
Self-citationA signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma
Zhao, R., Chen, Q., Qiao, P., Lu, Y., & Chen, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2046 · Cited by 3
Metadata
- Authors
- Battelli, M. G., Polito, L., Bortolotti, M., & Bolognesi, A.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2015-12-21
- Volume
- 5
- Issue
- 3
- Pages
- 546-557
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2272073785
- Cited by
- 162
- References
- 2
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Xanthine oxidoreductase in cancer: more than a differentiation marker. https://app.cochat.ai/papers/10.1002/cam4.601
- The paper
- Battelli, M. G., Polito, L., Bortolotti, M., & Bolognesi, A. (2016). Xanthine oxidoreductase in cancer: more than a differentiation marker. Cancer Medicine. https://doi.org/10.1002/cam4.601
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.